Clinicopathological Characteristics and Outcomes of Chinese Patients with Scanty Immune Deposits Lupus Nephritis: A Large Cohort Study from a Single Center

Table 2

Comparison of laboratory data between patients with scanty immune deposits and immune complex deposits lupus nephritis.

	Scanty immune deposits	Immune complex deposits	𝑃 value
Number of patients	40	276
Hemoglobin (g/L) (mean ± SD)	91.18±24.39	102.16±24.93	0.009
Urine protein (g/24 hours); (median; interquartile range)	4.04,; 1.96–5.36	4.34,; 2.20–7.07	0.348
Serum creatinine (mmol/dL); (median; interquartile range)	102,; 80.25–189.50	81,; 67–126	0.01
Number with positive ANA (%)	39 (97.5)	273 (98.9)	1
Number with positive anti-dsDNA (%)	25 (64.1)	191 (69.2)	0.521
Number with positive anti-Sm (%)	13 (33.3)	69 (25.0)	0.267
Number with positive anti-SSA (%)	16 (41.0)	124 (44.9)	0.646
Number with positive anti-SSB (%)	3 (7.9)	32 (11.6)	0.493
Number with positive anti-RNP (%)	12 (30.8)	84 (30.4)	0.966
Number with positive anticardiolipin (%)	2 (2/34, 6.9%)	17 (17/223, 7.6%)	1
Number with positive anti-β2 GP-1 (%)	4 (4/34, 6.9%)	15 (15/223, 6.7%)	1
Number with positive ANCA (%)	21 (52.5)	28 (10.1)	<0.001

𝑃<0.05, italic values refer to the significant value between the two groups.